Kodiak Sciences Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 59.52 million compared to USD 70.45 million a year ago. Basic loss per share from continuing operations was USD 1.13 compared to USD 1.35 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 USD | +2.98% | -2.38% | +7.89% |
Apr. 04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
Apr. 01 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.89% | 172M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KOD Stock
- News Kodiak Sciences Inc.
- Kodiak Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023